申请人:Nippon Shinyaku Co., Ltd.
公开号:US04927835A1
公开(公告)日:1990-05-22
Compounds of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof, wherein: R.sup.1 is cycloalkyl of 5 to 7 carbon atoms; aryl of 6 to 10 carbon atoms unsubstituted or substituted by straight or branched chain alkyl of 1 to 4 carbon atoms, halo or trifluoromethyl; or ##STR2## wherein A is oxygen, sulfur or NR.sup.5, wherein R.sup.5 is hydrogen, straight or branched chain alkyl of 1 to 4 carbon atoms or halo, and R.sup.6 is hydrogen, straight or branched chain alkyl of 1 to 4 carbon atoms or halo; R.sup.2 is straight or branched chain alkyl of 1 to 4 carbon atoms or cycloalkyl of 5 to 7 carbon atoms; and R.sup.3 and R.sup.4 are the same or different and each is hydrogen; straight or branched chain alkyl of 1 to 8 carbon atoms unsubstituted or substituted by hydroxy, acyloxy of 2 to 5 carbon atoms, carboxyl or carbamoyl; are useful for treating pain, inflammation and fever in humans and animals.
化合物的化学式(I):##STR1##或其药学上可接受的盐,其中:R.sup.1是5到7个碳原子的环烷基;6到10个碳原子的芳基,未取代或被1到4个碳原子的直链或支链烷基、卤素或三氟甲基取代;或##STR2##其中A是氧、硫或NR.sup.5,其中R.sup.5是氢、1到4个碳原子的直链或支链烷基或卤素,R.sup.6是氢、1到4个碳原子的直链或支链烷基或卤素;R.sup.2是1到4个碳原子的直链或支链烷基或5到7个碳原子的环烷基;R.sup.3和R.sup.4相同或不同,每个都是氢、未取代或被羟基、2到5个碳原子的酰氧基、羧基或氨基取代的1到8个碳原子的直链或支链烷基;可用于治疗人类和动物的疼痛、炎症和发热。